Results 251 to 260 of about 223,598 (343)

Relapse risk and outcome of discontinuing asparaginase in children with acute lymphoblastic leukemia. [PDF]

open access: yesAnn Hematol
Wang X   +17 more
europepmc   +1 more source

Impact of Adolescent and Young Adult Cancer Expertise in Oncologists on AYA Outcomes in Hodgkin Lymphoma: A Population‐Based Study in Ontario, Canada

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Purpose To determine whether adolescent and young adults (AYA) with Hodgkin lymphoma (HL) who are treated by oncologists with “AYA expertise” improve outcomes. Methods All AYA aged 15–21 years diagnosed with HL in Ontario, Canada between 1992 and 2012 were identified, and clinical data abstracted as part of the IMPACT cohort.
Eden C. Andrew   +5 more
wiley   +1 more source

Long-Term endocrine outcomes with special emphasis on the gonadal impact of acute lymphoblastic leukemia treatment in females. [PDF]

open access: yesAnn Hematol
Karakaş H   +9 more
europepmc   +1 more source

Trends in US Hematology/Oncology Physician Perceptions and Referral Practices for Hematopoietic Cell Transplant: A National Survey Conducted by NMDP

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Background To evaluate trends in allogeneic hematopoietic cell transplant (HCT) referral perceptions and practices, we compared surveys of Hematology‐Oncology (Hem‐Onc) physicians conducted in 2015 (N = 150), 2019 (N = 302), and 2024 (N = 183) and reported changes over time.
Aye Mon Thida   +7 more
wiley   +1 more source

Parent Perspectives on Physical Therapy for Their Child with Acute Lymphoblastic Leukemia: <i>The Light at the End of the Tunnel</i>. [PDF]

open access: yesCurr Oncol
Ospina PA   +7 more
europepmc   +1 more source

Minimal residual disease in solid tumors: Clinical applications and future directions

open access: yesCancer, Volume 132, Issue 3, 1 February 2026.
Abstract Minimal residual disease (MRD) refers to the presence of residual cancer cells or tumor‐derived fragments that persist after treatment and remain undetectable by conventional imaging or protein‐based assays. Circulating tumor DNA (ctDNA) has emerged as a dynamic biomarker for MRD detection.
Theresa Abdo   +8 more
wiley   +1 more source

Adipocytes Impair Mitoxantrone Cytotoxicity Against Acute Lymphoblastic Leukemia. [PDF]

open access: yesEJHaem
Cohen M   +6 more
europepmc   +1 more source

Pathway‐Informed Machine Learning Identifies Genetic Predictors of High‐Dose Methotrexate‐Induced Mucositis in Pediatric Acute Lymphoblastic Leukemia

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 2, Page 447-456, February 2026.
High‐dose methotrexate for pediatric cancer treatment is frequently associated with mucositis, which can lead to delayed or discontinued treatment and impact survival. While individual genetic variants have been implicated, the cumulative impact of genetic variation within relevant biological pathways remains unexplored.
Xiao Yu Cindy Zhang   +9 more
wiley   +1 more source

Acute Lymphoblastic Leukemia Associated with a t(l;l9)(q23;pl3) in an Adult.

open access: bronze, 1993
Hitoshi Ohno   +10 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy